Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 1, 1991
Effects of warm ischemia following harvesting of allograft cardiac valves
J St Louis, P Corcoran, S Rajan, et al.
British Journal of Clinical Pharmacology
|
February 1, 1993
Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril
E G Bevan, G T McInnes, J C Aldigier, et al.
Bioresource Technology
|
November 11, 2022
Applications of biomass-derived solvents in biomass pretreatment - Strategies, challenges, and prospects
Xianzhi Meng, Yunxuan Wang, Austin J Conte, et al.
Annals of Internal Medicine
|
July 15, 1997
Emergency department use of aspirin in patients with possible acute myocardial infarction
B B Saketkhou, F J Conte, M Noris, et al.
Leukemia & Lymphoma
|
November 30, 2013
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Michael J Conte, Deborah A Bowen, Gregory A Wiseman, et al.
Expert Review of Hematology
|
February 21, 2018
Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia
Neil E Kay, Betsy R LaPlant, Adam M Pettinger, et al.
The International Journal of Oral & Maxillofacial Implants
|
February 5, 2019
Patient-Centered Risk Assessment in Implant Treatment Planning
Donald A Curtis, Guo-Hao Lin, Alison Fishman, et al.
American Journal of Hematology
|
April 12, 2014
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells
Clive S Zent, Ronald P Taylor, Margaret A Lindorfer, et al.
American Journal of Hematology
|
September 24, 2017
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings
Paul J Hampel, Kari G Chaffee, Rebecca L King, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 12, 2018
Cross-cultural invariances in the architecture of shame
Daniel Sznycer, Dimitris Xygalatas, Elizabeth Agey, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 1, 1991
Effects of warm ischemia following harvesting of allograft cardiac valves
J St Louis, P Corcoran, S Rajan, et al.
British Journal of Clinical Pharmacology
|
February 1, 1993
Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril
E G Bevan, G T McInnes, J C Aldigier, et al.
Bioresource Technology
|
November 11, 2022
Applications of biomass-derived solvents in biomass pretreatment - Strategies, challenges, and prospects
Xianzhi Meng, Yunxuan Wang, Austin J Conte, et al.
Annals of Internal Medicine
|
July 15, 1997
Emergency department use of aspirin in patients with possible acute myocardial infarction
B B Saketkhou, F J Conte, M Noris, et al.
Leukemia & Lymphoma
|
November 30, 2013
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Michael J Conte, Deborah A Bowen, Gregory A Wiseman, et al.
Expert Review of Hematology
|
February 21, 2018
Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia
Neil E Kay, Betsy R LaPlant, Adam M Pettinger, et al.
The International Journal of Oral & Maxillofacial Implants
|
February 5, 2019
Patient-Centered Risk Assessment in Implant Treatment Planning
Donald A Curtis, Guo-Hao Lin, Alison Fishman, et al.
American Journal of Hematology
|
April 12, 2014
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells
Clive S Zent, Ronald P Taylor, Margaret A Lindorfer, et al.
American Journal of Hematology
|
September 24, 2017
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings
Paul J Hampel, Kari G Chaffee, Rebecca L King, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 12, 2018
Cross-cultural invariances in the architecture of shame
Daniel Sznycer, Dimitris Xygalatas, Elizabeth Agey, et al.
Page
of 8